A citation-based method for searching scientific literature

F Kheloufi, A Default, F Rouby, D Laugier-Castellan, M Boyer, B Rodrigues, J Ponte-Astoul, M J Jean-Pastor, O Blin, J Micallef. Eur J Clin Pharmacol 2017
Times Cited: 6







List of co-cited articles
28 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis.
Leàn Rolfes, Florence van Hunsel, Laura van der Linden, Katja Taxis, Eugène van Puijenbroek. Drug Saf 2017
39
66

ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.
Linda Härmark, Florence van Hunsel, Birgitta Grundmark. Drug Saf 2015
42
50

The value of patient reporting to the pharmacovigilance system: a systematic review.
Pedro Inácio, Afonso Cavaco, Marja Airaksinen. Br J Clin Pharmacol 2017
96
50

Patient Reporting in the EU: Analysis of EudraVigilance Data.
Marin Banovac, Gianmario Candore, Jim Slattery, Francois Houÿez, David Haerry, Georgy Genov, Peter Arlett. Drug Saf 2017
38
50

Adverse drug reaction reports of patients and healthcare professionals-differences in reported information.
Leàn Rolfes, Florence van Hunsel, Sarah Wilkes, Kees van Grootheest, Eugène van Puijenbroek. Pharmacoepidemiol Drug Saf 2015
37
50

Factors affecting patient reporting of adverse drug reactions: a systematic review.
Rania Al Dweik, Dawn Stacey, Dafna Kohen, Sanni Yaya. Br J Clin Pharmacol 2017
58
50

The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015.
Florence van Hunsel, Susan de Waal, Linda Härmark. Pharmacoepidemiol Drug Saf 2017
23
50

Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
Sarah Watson, Rebecca E Chandler, Henric Taavola, Linda Härmark, Birgitta Grundmark, Alem Zekarias, Kristina Star, Florence van Hunsel. Drug Saf 2018
24
50

[Adverse drug reactions: a pilot study on patient reporting through patient associations].
Daphney Nasrallah-Irles, Anne Castot, Laure Thomas, Samy Babai, Bernard Delorme, Hervé Le-Louët. Therapie 2008
7
33

Analysis of the effect of sentiment analysis on extracting adverse drug reactions from tweets and forum posts.
Ioannis Korkontzelos, Azadeh Nikfarjam, Matthew Shardlow, Abeed Sarker, Sophia Ananiadou, Graciela H Gonzalez. J Biomed Inform 2016
41
33

Vigi4Med Scraper: A Framework for Web Forum Structured Data Extraction and Semantic Representation.
Bissan Audeh, Michel Beigbeder, Antoine Zimmermann, Philippe Jaillon, Cédric Bousquet. PLoS One 2017
7
33

Evaluating Social Media Networks in Medicines Safety Surveillance: Two Case Studies.
Preciosa M Coloma, Benedikt Becker, Miriam C J M Sturkenboom, Erik M van Mulligen, Jan A Kors. Drug Saf 2015
30
33


Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features.
Azadeh Nikfarjam, Abeed Sarker, Karen O'Connor, Rachel Ginn, Graciela Gonzalez. J Am Med Inform Assoc 2015
181
33

Quality criteria for early signals of possible adverse drug reactions.
I R Edwards, M Lindquist, B E Wiholm, E Napke. Lancet 1990
73
33





Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review.
Jérémy Lardon, Redhouane Abdellaoui, Florelle Bellet, Hadyl Asfari, Julien Souvignet, Nathalie Texier, Marie-Christine Jaulent, Marie-Noëlle Beyens, Anita Burgun, Cédric Bousquet. J Med Internet Res 2015
55
33




Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial.
Gilles Defer, Florian Le Caignec, Sophie Fedrizzi, François Montastruc, Damien Chevanne, Jean-Jacques Parienti, Laure Peyro-Saint-Paul. Trials 2018
11
33

Experiences with adverse drug reaction reporting by patients: an 11-country survey.
Florence van Hunsel, Linda Härmark, Shanthi Pal, Sten Olsson, Kees van Grootheest. Drug Saf 2012
90
33



Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
A J Avery, C Anderson, C M Bond, H Fortnum, A Gifford, P C Hannaford, L Hazell, J Krska, A J Lee, D J McLernon,[...]. Health Technol Assess 2011
163
33

Causality assessment in pharmacovigilance: The French method and its successive updates.
Ghada Miremont-Salamé, Hélène Théophile, Françoise Haramburu, Bernard Bégaud. Therapie 2016
165
16

21st century pharmacovigilance: efforts, roles, and responsibilities.
Peter J Pitts, Hervé Le Louet, Yola Moride, Rena M Conti. Lancet Oncol 2016
31
16

First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
Geneviève Durrieu, Aurore Palmaro, Laure Pourcel, Céline Caillet, Angeline Faucher, Alexis Jacquet, Shéhérazade Ouaret, Marie Christine Perault-Pochat, Carmen Kreft-Jais, Anne Castot,[...]. Drug Saf 2012
20
16


Mining adverse drug reactions from online healthcare forums using hidden Markov model.
Hariprasad Sampathkumar, Xue-wen Chen, Bo Luo. BMC Med Inform Decis Mak 2014
34
16



Strategies to improve adverse drug reaction reporting: a critical and systematic review.
Cristian Gonzalez-Gonzalez, Elena Lopez-Gonzalez, Maria T Herdeiro, Adolfo Figueiras. Drug Saf 2013
66
16


[Comparative relevance of declaration of side effects by patients and health professionals].
Audrey Lagneau, Caroline Vigier, Alexandre Marianna, Rachel Serfaty, Fanny Rocher, Anne Spreux, Milou-Daniel Drici. Therapie 2017
6
16

[Causes for the underreporting of adverse drug events by health professionals: a systematic review].
Fabiana Rossi Varallo, Synara de Oliveira Paim Guimarães, Samir Antonio Rodrigues Abjaude, Patricia de Carvalho Mastroianni. Rev Esc Enferm USP 2014
54
16

Social media and pharmacovigilance: A review of the opportunities and challenges.
Richard Sloane, Orod Osanlou, David Lewis, Danushka Bollegala, Simon Maskell, Munir Pirmohamed. Br J Clin Pharmacol 2015
58
16

Use of the internet as a health information resource among French young adults: results from a nationally representative survey.
François Beck, Jean-Baptiste Richard, Viet Nguyen-Thanh, Ilaria Montagni, Isabelle Parizot, Emilie Renahy. J Med Internet Res 2014
159
16

Drug related problems with Antiparkinsonian agents: consumer Internet reports versus published data.
Sabrina Schröder, York Francis Zöllner, Marion Schaefer. Pharmacoepidemiol Drug Saf 2007
25
16

The validity and reliability of a signal impact assessment tool.
Leàn Rolfes, Judith Kolfschoten, Florence van Hunsel, Eugène van Puijenbroek. Pharmacoepidemiol Drug Saf 2016
9
16

Patient perspectives of dabigatran: analysis of online discussion forums.
Mary S Vaughan Sarrazin, Peter Cram, Alexandur Mazur, Melissa Ward, Heather Schacht Reisinger. Patient 2014
27
16

Analysis of patients' narratives posted on social media websites on benfluorex's (Mediator® ) withdrawal in France.
M Abou Taam, C Rossard, L Cantaloube, N Bouscaren, G Roche, L Pochard, F Montastruc, A Herxheimer, J L Montastruc, H Bagheri. J Clin Pharm Ther 2014
25
16





Utilizing social media data for pharmacovigilance: A review.
Abeed Sarker, Rachel Ginn, Azadeh Nikfarjam, Karen O'Connor, Karen Smith, Swetha Jayaraman, Tejaswi Upadhaya, Graciela Gonzalez. J Biomed Inform 2015
202
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.